We have 10 content tracks on the agenda for the Festival, taking place across 5 theatres. To view the sessions for each theme, click on the track title.
Advancing application in healthcare, with a particular emphasis on genomics in the NHS, considerations for patients, other healthcare systems, clinician education and the role of innovation in accelerating clinical impact.
Capitalizing on the changing applications of genomics and related technologies in understanding disease and physiology, improving ecosystems, enhancing the environment and population genomics. The theme will also address the state of genomics research in the UK in a fast-changing political and economic environment.
Examining genomic-driven advances in cancer disease research, drug/therapy development and diagnosis/treatment. This theme will bring together cancer researchers, drug developers and clinicians/clinical labs to deliver case studies and topic-led discussions.
Assessing the impact of advanced analytics, including AI and ML-led technologies, on our understanding and applications of genomic data, to gather and translate intelligence into incredible advances in life sciences.
Gathering genomics data is just the start. The generation and leverage of biodata is transforming entire industries. Gathering, organizing, combining/integrating, analysing and interpreting diverse bio-data sets, including genomics data, will be covered in expansive presentations and discussions.
Examining the role of genomics and related technologies in advancing and maturing drug development, including pharmacogenomics, clinical development, generation of preclinical models, genome editing, gene and cell therapy and therapies/drugs that engage directly with the genome.
Exploring how genomics influences our understanding of the biology of rare disease and translates into clinical care. These sessions will include developments in the genomic basis of rare diseases, mechanisms and therapeutic approaches, as well as opportunities to enhance diagnosis in clinical practice.
Identifying and understanding the economics of scaling both genomic medicine and personal applications, as well as the practicalities of launching, funding and growing a genomic business, as well as translating innovation out of the clinical. To include perspectives from the investor and business world.
Why everyone should have their genome sequenced, and how to make it happen. An insight into innovation, technology, personal leveraging of the genome, new platforms, changing perspectives on genomics in society (and in diverse communities), the critical issue of privacy and the role of blockchain.
Blue sky innovations, the intersection of bleeding/leading edge genomics technologies and the role of genomics innovation in transforming diverse fields in life sciences. Will include genome editing, cutting edge advances in diagnostics and discussion around promoting innovation in genomics.